The Case for Drug-eluting vs Bare-metal Stents Podcast

Interventional Cardiology Podcast Series: The Case for Drug-Eluting vs Bare-Metal Stents in Coronary Artery Disease Patients

Free registration required to listen to the podcast.

sunil-raoIs a drug-eluting stent or a bare-metal stent the safest option for patients requiring percutaneous coronary intervention (PCI), including those with a bleeding history or a risk for bleeding? What are the revascularization and stent thrombosis risks?

Sunil Rao, MD, and Ajar Kochar, MD, discuss the case of a 62-year-old patient with a history of hypertension, tobacco use, and recent diverticular-related bleeding. As part of their discussion, they refer to the NORSTENT study published in the most recent issue of The New England Journal of Medicine. The article, “Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease,” describes a randomized clinical trial involving more than 9,000 patients who underwent PCI with the implantation of either drug-eluting stents or bare-metal stents.

This is the sixth of eight monthly Interventional Cardiology podcasts from DCRI Education, whose mission it is to accelerate the adoption of research to practice.